UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis

Clinical infectious diseases, 2009-06, Vol.48 (12), p.1676-1684

2009

Volltextzugriff (PDF)

Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study

The Journal of infectious diseases, 2008-04, Vol.197 (8), p.1133-1144

2008

Volltextzugriff (PDF)

Sexually Transmitted Diseases in Travelers

Clinical infectious diseases, 2001-04, Vol.32 (7), p.1063-1067

2001

Volltextzugriff (PDF)

A Randomized, Double-Blind, Double-Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

Clinical infectious diseases, 2001-11, Vol.33 (9), p.1447-1454

2001

Volltextzugriff (PDF)

Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up

The Journal of infectious diseases, 2008-04, Vol.197 (8), p.1145-1155

2008

Volltextzugriff (PDF)

Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2372-2378

2011

Volltextzugriff (PDF)

Spectrum of Illness in International Migrants Seen at GeoSentinel Clinics in 1997–2009, Part 2: Migrants Resettled Internationally and Evaluated for Specific Health Concerns

Clinical infectious diseases, 2013-04, Vol.56 (7), p.925-933

2013

Volltextzugriff (PDF)

Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

Clinical infectious diseases, 2013-07, Vol.57 (1), p.112-121

2013

Volltextzugriff (PDF)

Sex and Gender Differences in Travel-Associated Disease

Clinical infectious diseases, 2010-03, Vol.50 (6), p.826-832

2010

Volltextzugriff (PDF)

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

Journal of antimicrobial chemotherapy, 2012-08, Vol.67 (8), p.2020-2028

2012

Volltextzugriff (PDF)

Incidence of Malignancies in HIV-Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

Clinical infectious diseases, 2010-05, Vol.50 (9), p.1316-1321

2010

Volltextzugriff (PDF)

Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz

Journal of antimicrobial chemotherapy, 2014-04, Vol.69 (4), p.1090-1097

2014

Volltextzugriff (PDF)

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial

Journal of antimicrobial chemotherapy, 2012-03, Vol.67 (3), p.685-690

2012

Volltextzugriff (PDF)

Travel-Associated Illness in Older Adults (>60 y)

Journal of travel medicine, 2012-05, Vol.19 (3), p.169-177

2012

Volltextzugriff (PDF)

Risk of Developing Specific AIDS-Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis

Clinical infectious diseases, 2009-08, Vol.49 (4), p.612-622

2009

Volltextzugriff (PDF)

Changes Over Time in Risk Factors for Cardiovascular Disease and Use of Lipid-Lowering Drugs in HIV-Infected Individuals and Impact on Myocardial Infarction

Clinical infectious diseases, 2008-04, Vol.46 (7), p.1101-1110

2008

Volltextzugriff (PDF)

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1224-1227

2012

Volltextzugriff (PDF)

Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort

Journal of antimicrobial chemotherapy, 2005-07, Vol.56 (1), p.190-195

2005

Volltextzugriff (PDF)

Rate of CD4+ Cell Count Increase over Periods of Viral Load Suppression: Relationship with the Number of Previous Virological Failures

Clinical infectious diseases, 2010-08, Vol.51 (4), p.456-464

2010

Volltextzugriff (PDF)

Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)

Journal of antimicrobial chemotherapy, 2006-06, Vol.57 (6), p.1055-1064

2006

Volltextzugriff (PDF)

HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations

Journal of antimicrobial chemotherapy, 2003-11, Vol.52 (5), p.776-781

2003

Volltextzugriff (PDF)

Rifabutin Versus Placebo in Combination with Three Drugs in the Treatment of Nontuberculous Mycobacterial Infection in Patients with AIDS

Clinical infectious diseases, 1996-04, Vol.22 (4), p.705-708

1996

Volltextzugriff (PDF)

Age-Specific Anti-Hepatitis A Virus Seroepidemiology in Italian Travelers: Indications for Anti-Hepatitis A Vaccination

Journal of travel medicine, 1996-12, Vol.3 (4), p.214-218

1996

Volltextzugriff (PDF)

Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens. Discussion

Clinical infectious diseases, 1996, Vol.22, p.S61-S69

1996

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SeriePhysics Letters. B

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(24)
Tagungsberichte
(1)

Sprache

Englisch
(25)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(23)
Infectious Diseases
(23)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Microbiology
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Female
(19)
Male
(19)
Adult
(17)
Hiv
(15)
Middle Aged
(15)
Immunology
(14)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(12)
Human Immunodeficiency Virus
(12)
Pharmacology. Drug Treatments
(12)
Aged
(11)
Aids
(10)
Hiv Infections - Drug Therapy
(10)
Viral Diseases
(10)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford University Press Journals Current
(25)
EZB Free E-Journals
(25)
Journals@Ovid Complete
(25)
MEDLINE
(23)
Jstor Complete Legacy
(15)
Single Journals
(15)
Ingenta
(3)
Wiley Online Library - AutoHoldings Journals
(2)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis

Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

Sexually Transmitted Diseases in Travelers

A Randomized, Double-Blind, Double-Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up

Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy

Spectrum of Illness in International Migrants Seen at GeoSentinel Clinics in 1997–2009, Part 2: Migrants Resettled Internationally and Evaluated for Specific Health Concerns

Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

Sex and Gender Differences in Travel-Associated Disease

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

Incidence of Malignancies in HIV-Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial

Travel-Associated Illness in Older Adults (>60 y)

Risk of Developing Specific AIDS-Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis

Changes Over Time in Risk Factors for Cardiovascular Disease and Use of Lipid-Lowering Drugs in HIV-Infected Individuals and Impact on Myocardial Infarction

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort

Rate of CD4+ Cell Count Increase over Periods of Viral Load Suppression: Relationship with the Number of Previous Virological Failures

Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)

HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations

Rifabutin Versus Placebo in Combination with Three Drugs in the Treatment of Nontuberculous Mycobacterial Infection in Patients with AIDS

Age-Specific Anti-Hepatitis A Virus Seroepidemiology in Italian Travelers: Indications for Anti-Hepatitis A Vaccination

Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens. Discussion

Aktive Filter

Suchergebnisse filtern